4//SEC Filing
Regulus Therapeutics Inc. 4
Accession 0001209191-14-073234
CIK 0001505512operating
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 7:36 PM ET
Size
5.4 KB
Accession
0001209191-14-073234
Insider Transaction Report
Form 4
GRINT PAUL C
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-12-02+50,870→ 50,870 totalExercise: $17.76Exp: 2024-12-01→ Common Stock (50,870 underlying)
Footnotes (1)
- [F1]25% of the shares will vest on January 1, 2016 and the remainder of the shares will vest in equal installments on a monthly basis thereafter, such that the option is fully vested on January 1, 2019.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001505512
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 7:36 PM ET
- Size
- 5.4 KB